Many of these advances will offer vastly improved outcomes for patients, therapies for hitherto difficult-to-treat diseases or conditions, improved manufacturing efficiency, or better use of valuable medical professional resources. According to experts, some 130 new nanotechnology-based drugs and delivery systems were already under development in 2006.
The Institute of Nanotechnology, global leaders in nanotechnology information services, is organising its second annual nanomedicine conference and exhibition ‘Investing in Medical Nanotechnology II’, which will showcase the latest developments in nanomedicine and potential routes to financing. The two day event will see leading multinational companies such as Philips, AstraZeneca, GE Healthcare, GlaxoSmithKline, Volcano Corporation and Fresenius Medical Care sharing their vision on the impacts of nanomedicine on healthcare and providing a window on their activities in the area. The conference will also see top industry figures offering their views on how to manage ‘risks and uncertainties’ as well as the challenges in integrating nanomedicine into established pharmaceutical and medical device business models.
The Head of ‘Nanosciences and Nanotechnologies’ unit at The European Commission will outline the EC’s nanomedicine plan and how some of the €800million dedicated under FP7 will be targeted towards new nanotechnology-based treatments. The Wellcome Trust will present details about their funding priorities and new technology transfer initiatives, and the chairman of the US-based Aesis Research Group will discuss new business models, financing and valuation in medical nanotechnology and suggest ideas for building value.
The event will also see a number of innovative small companies present novel nanomedical technologies and presentations from top scientists from as far away as India and Malaysia. The associated exhibition will showcase new innovations in nanomedicine and will provide a unique opportunity to network with potential partners.
Investing in Medical Nanotechnology II builds upon the success of the inaugural event held last year to bring the latest developments in the exciting and dynamic new field of nanomedicine. The event is sponsored by Marks & Clerk, MTI Partners and Tinytech Jobs and will take place on 28-29 November at the historic and prestigious Royal College of Surgeons in London. Further details are available at http://nanomednet.org/conference07/ or alternatively contact Tiju Joseph at the Institute of Nanotechnology on +44 (0) 141 330 8734.
Tiju Joseph | alfa
Conference to pave the way for new therapies
17.10.2018 | Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.
Berlin5GWeek: Private industrial networks and temporary 5G connectivity islands
16.10.2018 | FOKUS - Fraunhofer-Institut für Offene Kommunikationssysteme
Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz (Germany) together with scientists from Dresden, Leipzig, Sofia (Bulgaria) and Madrid (Spain) have now developed and characterized a novel, metal-organic material which displays electrical properties mimicking those of highly crystalline silicon. The material which can easily be fabricated at room temperature could serve as a replacement for expensive conventional inorganic materials used in optoelectronics.
Silicon, a so called semiconductor, is currently widely employed for the development of components such as solar cells, LEDs or computer chips. High purity...
Augsburg chemists present a new technology for compressing, storing and transporting highly volatile gases in porous frameworks/New prospects for gas-powered vehicles
Storage of highly volatile gases has always been a major technological challenge, not least for use in the automotive sector, for, for example, methane or...
When we put water in a freezer, water molecules crystallize and form ice. This change from one phase of matter to another is called a phase transition. While this transition, and countless others that occur in nature, typically takes place at the same fixed conditions, such as the freezing point, one can ask how it can be influenced in a controlled way.
We are all familiar with such control of the freezing transition, as it is an essential ingredient in the art of making a sorbet or a slushy. To make a cold...
Thin organic layers provide machines and equipment with new functions. They enable, for example, tiny energy recuperators. In future, these will be installed...
Das Zusammenspiel aus Struktur und Dynamik bestimmt die Funktion von Proteinen, den molekularen Werkzeugen der Zelle. Durch Fortschritte in der...
17.10.2018 | Event News
16.10.2018 | Event News
02.10.2018 | Event News
19.10.2018 | Life Sciences
19.10.2018 | Physics and Astronomy
19.10.2018 | Trade Fair News